Download Files:
Products Details
Product Description
– NWP-0476 is BCL-2/BCL-xL inhibitor. NWP-0476 has a modified structure with fine-tuned BCL-xL activity. NWP-0476 can be used for relapsed T-acute lymphoblastic leukemia (T-ALL) research[1].
Web ID
– HY-155188
Shipping
– Room temperature
Molecular Formula
– C47H53ClN8O8S
References
– [1]Saygin C, et al. Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia. Clin Cancer Res. 2023 Aug 15;29(16):3151-3161.
CAS Number
– 2290611-26-4
Molecular Weight
– 925.49
SMILES
– ClC1=CC=C(C2=C(CN3CCN(C4=CC=C(C(NS(=O)(C5=CC=C(NC[C@H]6OCCOC6)C([N+]([O-])=O)=C5)=O)=O)C(N7CCCOC8=C7C=C9C(NC=C9)=N8)=C4)CC3)CCC(C)(C)C2)C=C1
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Bcl-2 Family
Pathway
– Apoptosis
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
